Organization

University of Adelaide

2 clinical trials

8 abstracts

Abstract
ASC4FIRST, a pivotal phase 3 study of asciminib (ASC) vs investigator-selected tyrosine kinase inhibitors (IS TKIs) in newly diagnosed patients (pts) with chronic myeloid leukemia (CML): Primary results.
Org: South Australian Health and Medical Research Institute, Universitätsklinikum Jena, Akita University Hospital, The University of Texas MD Anderson Cancer Center, University of Chicago,
Abstract
Whole exome correlates in metastatic hormone sensitive prostate cancer (mHSPC): Results from E3805 CHAARTED.
Org: Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, University College London Cancer Institute, South Australian Immunogenomics Cancer Institute, University of Adelaide,
Clinical trial
Immunisation for Adolescents Against Serious Communicable Diseases
Status: Recruiting, Estimated PCD: 2024-12-31
Abstract
Patient reported quality of life (QOL) and survival outcomes: Analysis of ECOG-ACRIN E3805 chemohormonal androgen ablation randomized trial (CHAARTED) in prostate cancer (PCa).
Org: Beth Israel Deaconess Medical Center, Dana Farber Cancer Institute, Boston, MA, ECOG-ACRIN Biostatistics Center, University of Wisconsin Hospital and Clinics, Johns Hopkins Kimmel Cancer Center,
Abstract
ASCEND: A randomised, double-blinded, phase II study of gemcitabine and nab‐paclitaxel with CEND‐1/LSTA1 or placebo in patients with untreated metastatic pancreatic ductal adenocarcinoma.
Org: St. John of God Hospital Subiaco, Queen Elizabeth Hospital, University of Adelaide, Woodville, St. George Hospital,
Abstract
Cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Results of a phase II/III, placebo-controlled, randomised trial.
Org: NHMRC Clinical Trials Centre, The University of Sydney, Northern Beaches Hospital, University of Adelaide, Campbelltown Hospital,
Abstract
Circulating ether lipids in prostate cancer.
Org: Chris O'Brien Lifehouse, Garvan Institute of Medical Research, Baker Institute, Baker Heart and Diabetes Institute, St Vincent's Hospital,
Abstract
A multinational qualitative study in giant cell arteritis: patient perceptions of diagnosis, treatment, impact on health-related quality of life and contextual factors
Org: University of the West of England, Bristol, Bristol University of Oxford, Oxford University Hospitals Bristol NHS Trust, University of Leeds, University of Adelaide,
Abstract
BIOMARKERS OF BONE ACTIVITY IN RHEUMATOID ARTHRITIS SYNOVIAL TISSUE AND THEIR RELATIONSHIP WITH CLINICAL OUTCOME
Org: Flinders University, Adelaide, SA, Australia, Royal Adelaide Hospital, University of Adelaide, Flinders Medical Centre,